1,180 reports of this reaction
1.5% of all CALCIUM GLUCONATE reports
#13 most reported adverse reaction
SYSTEMIC LUPUS ERYTHEMATOSUS is the #13 most commonly reported adverse reaction for CALCIUM GLUCONATE, manufactured by WG Critical Care, LLC. There are 1,180 FDA adverse event reports linking CALCIUM GLUCONATE to SYSTEMIC LUPUS ERYTHEMATOSUS. This represents approximately 1.5% of all 80,205 adverse event reports for this drug.
Patients taking CALCIUM GLUCONATE who experience systemic lupus erythematosus should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SYSTEMIC LUPUS ERYTHEMATOSUS is a less commonly reported adverse event for CALCIUM GLUCONATE, but still significant enough to appear in the safety profile.
In addition to systemic lupus erythematosus, the following adverse reactions have been reported for CALCIUM GLUCONATE:
The following drugs have also been linked to systemic lupus erythematosus in FDA adverse event reports:
SYSTEMIC LUPUS ERYTHEMATOSUS has been reported as an adverse event in 1,180 FDA reports for CALCIUM GLUCONATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
SYSTEMIC LUPUS ERYTHEMATOSUS accounts for approximately 1.5% of all adverse event reports for CALCIUM GLUCONATE, making it a notable side effect.
If you experience systemic lupus erythematosus while taking CALCIUM GLUCONATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.